B iodesix has expanded its collaboration with Bio-Rad Laboratories for the development and clinical validation of in vitro ...

One recent obstacle to drug delivery research is an observed weak correlation between in vitro and in vivo performance. When nanoparticles are applied intravenously, they face several obstacles that ...

DNA recovered from 1,000-year-old dried feces indicates that intestinal infections from pinworm or Shingella may have plagued ...

WESTBURY, N.Y., March 9, 2017 /PRNewswire/ — BioreclamationIVT has acquired TransCell Science, a privately held contract research organization (CRO) specializing in the use of primary cells for ...

A collaborative research group has developed a novel therapeutic candidate that may improve the prognosis of severe cutaneous ...

Biodesix, Inc., a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement ...

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced a collaboration with Oregon ...

The awards recognize ORISE program participants for scientific achievement, professional growth, project contributions and ...

Researchers have developed a CRISPR-based assay that can sensitively and non-invasively detect a biomarker of acute kidney rejection in urine. This could someday help diagnose rejection earlier and ...

Reliable assay reproducibility is the bedrock of credible clinical trials, particularly in hemostasis diagnostics where ...